mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.09 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.09 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.09 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.09 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.086 |
0.09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.09 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.09 |